Specification
| Target | PSMA |
| Reactivities | Human |
| Biosimilar | Rosbio |
| Isotype | Human IgG1(E356D/M358L)-kappa |
| Property | Antibody |
| Alternative | Cell growth-inhibiting gene 27 protein; cell growth-inhibiting protein 27; EC 3.4.17.21; FGCP; folate hydrolase (prostate-specific membrane antigen) 1; Folate hydrolase 1; FOLH1; FOLHNAALADase I; Folylpoly-gamma-glutamate carboxypeptidase; GCP2; GCPII; GCPIImGCP; glutamate carboxylase II; glutamate carboxypeptidase 2; Glutamate carboxypeptidase II; Membrane glutamate carboxypeptidase; mopsm; NAALAD1; NAALAD1N-acetylated-alpha-linked acidic dipeptidase I; NAALADase I; NAALAdase; N-acetylated alpha-linked acidic dipeptidase 1; prostate specific membrane antigen variant F; Prostate-specific membrane antigen; PSMA; PSMAFGCP; PSMPteroylpoly-gamma-glutamate carboxypeptidase |
| Recommend Isotype | Anti-HEL Human IgG1(E356D/M358L)-Kappa Isotype control |
| Formulation Buffer | PBS, pH 7.4,Contains no stabilizers or preservatives |
| Recommend Buffer | PBS, pH 7.4,Contains no stabilizers or preservatives. |
| Endotoxin | <1EU/mg Determined by LAL gel clotting assay |
| Purity | >97% Determined by SDS-PAGE |
| Sterility | 0.2 μM filtered |
| Expression Host | CHO |
| Purification method | Protein A |
| Storage | The product should be stored at the original stock concentration at 4°C. Avoid freeze-thaw cycles. |
| Note | Due to the variability in applications, investigators should consult application references to estimate the appropriate dose or concentration. This dose or concentration can then be further optimized through experimental methods such as dose-response or titration experimentsThe sequence of this product comes from:IMGT |
Background
QC Data
| Note | Please contact us for QC Data |
| Product Image (Reference Only) |  |